Biotechnological Ricin for Immunological Studies from Canada
Recombinant ricin toxin produced through biotech processes for studying immune responses and antibody production. Classified in HTS 3002.49.0010 as a modified toxin for diagnostic and therapeutic research. Used in labs to develop countermeasures against bioterrorism agents.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include biotech origin certificate and sequence data to justify classification under modified immunological products
• Use IATA-compliant packaging for air import; verify receiver's BSL-3 lab status to prevent denial